TSS
WINT

Two Sigma Securities’s Windtree Therapeutics Inc WINT Stock Holding History

Two Sigma Securities’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-988
Closed -$16K – 308
2015
Q1 		$16K Buy
+988
New +$19.5K 0.02% 184

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Securities's WINT Position: Q2 2015 in Review

Two Sigma Securities sold out of Windtree Therapeutics Inc (WINT) in Q2 2015, closing a stake of 988 shares — an estimated $16K sold.

Two Sigma Securities first reported a position in WINT in Q1 2015 and held it in 1 quarter. The position peaked at $16K in Q1 2015. 52 funds tracked by Wall St. Rank hold WINT as of Q2 2015.

  • Two Sigma Securities reported no remaining Windtree Therapeutics Inc position as of Q2 2015 after selling out during the quarter.
  • Two Sigma Securities sold 988 Windtree Therapeutics Inc shares in Q2 2015, an estimated $16K.
  • Two Sigma Securities first reported a position in Windtree Therapeutics Inc in Q1 2015 and held it in 1 quarter.
  • Two Sigma Securities's Windtree Therapeutics Inc position peaked at $16K in Q1 2015.
  • 52 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2015.

Based on Two Sigma Securities's 13F filing for Q2 2015, filed 14 Aug 2015.